CVS Group PLC - Norfolk, England-based provider of veterinary services - On Thursday, says sales increased 6.6% to £341.8 million in the six months to December 31 from £320.5 million a year prior. Says adjusted earnings before interest, taxes, depreciation and amortisation increases by 4.5% to £67.4 million from £64.5 million a year prior with an adjusted Ebitda margin of 19.7% in line with target. Like-for-like sales for the period compared to the first half were hit by 1.1% by a continuation of softer market conditions in the UK most notably in online retail and laboratory businesses. Performance across the core Veterinary Practice division is flat and CVS expects to deliver year on year growth in this division and across the group in the second half. Estimates impact to year ending June 30 2026 of £8 million from national insurance scheme changes and £3 million from national living wage/national minimum wage rises. Is targeting cost synergies in Australia and efficiencies in the UK to offset these increases.
Current stock price: 980.00 pence, down 0.6% in London on Friday
12-month change: down 42%
Copyright 2025 Alliance News Ltd. All Rights Reserved.
